Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MTIX

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MTIX
DateTimeSourceHeadlineSymbolCompany
09/12/200503:01PR Newswire (US)ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
15/11/200501:11PR Newswire (US)ev3 Inc. and Micro Therapeutics, Inc. Announce Merger AgreementNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200523:01PR Newswire (US)Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net SalesNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200523:00PR Newswire (US)ev3 Inc. Reports Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
22/10/200500:00PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005NASDAQ:MTIXMicro Therapeutics (MM)
11/10/200500:30PR Newswire (US)ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
10/10/200523:30PR Newswire (US)Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.NASDAQ:MTIXMicro Therapeutics (MM)
06/10/200504:04PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
03/08/200507:51PR Newswire (US)Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005NASDAQ:MTIXMicro Therapeutics (MM)
03/08/200507:48PR Newswire (US)ev3 Inc. Reports Second Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
28/07/200506:27PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005NASDAQ:MTIXMicro Therapeutics (MM)
22/07/200508:27PR Newswire (US)ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
22/07/200508:08PR Newswire (US)Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
07/07/200508:30PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
29/04/200507:14PR Newswire (US)Micro Therapeutics Reports 50% Net Sales Increase for 2005 First QuarterNASDAQ:MTIXMicro Therapeutics (MM)
26/04/200503:28PR Newswire (US)Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005NASDAQ:MTIXMicro Therapeutics (MM)
22/03/200508:57PR Newswire (US)ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
11/02/200507:23PR Newswire (US)Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
10/02/200523:45PR Newswire (US)Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on FebruaryNASDAQ:MTIXMicro Therapeutics (MM)
08/02/200510:40PR Newswire (US)Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005NASDAQ:MTIXMicro Therapeutics (MM)
01/02/200523:00PR Newswire (US)Micro Therapeutics Receives $3.7 Million PaymentNASDAQ:MTIXMicro Therapeutics (MM)
30/12/200404:13PR Newswire (US)Micro Therapeutics Consolidates Manufacturing CapabilitiesNASDAQ:MTIXMicro Therapeutics (MM)
07/12/200407:04PR Newswire (US)ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
11/11/200401:00PR Newswire (US)ev3 International Files Lawsuit Against Distributors in Hong Kong and PhoenixNASDAQ:MTIXMicro Therapeutics (MM)
04/11/200423:00PR Newswire (US)Micro Therapeutics Reports 2004 Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
02/11/200407:24PR Newswire (US)Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4NASDAQ:MTIXMicro Therapeutics (MM)
22/10/200401:47PR Newswire (US)FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long StentsNASDAQ:MTIXMicro Therapeutics (MM)
21/09/200423:01PR Newswire (US)ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft UseNASDAQ:MTIXMicro Therapeutics (MM)
27/08/200402:33PR Newswire (US)ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting ProceduresNASDAQ:MTIXMicro Therapeutics (MM)
19/08/200403:51PR Newswire (US)Micro Therapeutics Completes Issuance of Common Stock for Exchangeable NotesNASDAQ:MTIXMicro Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:MTIX